Bausch Health
BHC
#4170
Rank
C$3.64 B
Marketcap
C$9.82
Share price
-1.91%
Change (1 day)
-10.14%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): C$1.34

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is C$1.33. In 2024 the company made an earnings per share (EPS) of C-$0.16 an increase over its 2023 EPS that were of C-$2.21.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$1.34-917.43%
2024C-$0.16-92.59%
2023C-$2.21160.89%
2022C-$0.85-76.64%
2021C-$3.6368.45%
2020C-$2.16-68.91%
2019C-$6.94-57.11%
2018C-$16.18-272.22%
2017C$9.39-199.29%
2016C-$9.46798.7%
2015C-$1.05-128.31%
2014C$3.72-204.62%
2013C-$3.55602.7%
2012C-$0.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
C-$1.30-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C-$0.33-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA